Skip to main content

Advertisement

Log in

Collision Tumor of Primary Laryngeal Mucosal Melanoma and Invasive Squamous Cell Carcinoma with IL-17A and CD70 Gene Over-Expression

  • Case Report
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The most common primary malignancy of the larynx is the squamous cell carcinoma (SCC). The primary malignant melanoma is quite rare in this location. Less than 60 cases of laryngeal melanomas have been reported to date. To our knowledge, collision primary malignant melanoma and invasive squamous cell carcinoma in the vocal cords has not been reported. We report a 53-year-old male patient who was diagnosed with a collision tumor of laryngeal melanoma and invasive SCC. Multiple Th17 pathway related genes including CTLA-4, IL-17A-F, PLZF, FoxP3, RorγT, CD27, and CD70 were analyzed by reverse transcriptase-polymerase chain reaction (Rt–PCR) in this case. Both IL-17A and CD70 genes were detected in this case of collision tumor. The results may define useful biomarkers for early diagnosis of mucosal melanoma and open an immunotherapeutic field for clinical management with the potential benefit from the immunomodulators that enhance both genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489–501.

    Article  PubMed  Google Scholar 

  2. Barnes L. Surgical pathology of the head and neck, 3rd edn. Informa Healthcare. New York; 2008. pp. 137–160.

  3. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base Report on cutaneous and non cutaneous melanoma. A summary of 84,836 cases from the past decade. Cancer. 1998;83:1664–78.

    Article  CAS  PubMed  Google Scholar 

  4. Wagner M, Morris CG, Werning JW, et al. Mucosal melanoma of the head and neck. Am J Clin Oncol. 2008;31:43–8.

    Article  PubMed  Google Scholar 

  5. Wenig BM. Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study in four patients and a review of the article. Cancer. 1995;75:1568–77.

    Article  CAS  PubMed  Google Scholar 

  6. Wang W, Edington HD, Rao UN, et al. Effects of high-dose IGNα2b on regional lymph node metastases of human melanoma: modulation of STAT5, Foxp3, and IL-17. Clin Cancer Res. 2008;14:8314–20.

    Article  CAS  PubMed  Google Scholar 

  7. Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol. 2007;56:828–34.

    Article  PubMed  Google Scholar 

  8. Shah JP, Huvos AG, Strong EW. Mucosal melanomas of the head and neck. Am J Surg. 1977;134:531–5.

    Article  CAS  PubMed  Google Scholar 

  9. Reuter VE, Woodruff JM. Melanoma of the larynx. Laryngoscope. 1986;94:389–93.

    Google Scholar 

  10. Terada T, Saeki N, Toh K, et al. Primary malignant melanoma of the larynx: a case report and review literature. Auris Nasus Larynx. 2007;34:105–10.

    Article  PubMed  Google Scholar 

  11. Kim H, Park CI. Primary malignant laryngeal melanoma: report of a case with a review of literature. Yonsei Med J. 1982;23:118–22.

    CAS  PubMed  Google Scholar 

  12. Tomidokoro Y, Hayashi R, Yamasaki M, et al. Simultaneous squamous cell carcinoma with leimomyosarcoma of the larynx. Auris Nasus Larynx. 2009;36:239–43.

    Article  PubMed  Google Scholar 

  13. Medina-Banegas A, Osete-Albaladejo JM, Capitan-Guarnizo A, et al. Double tumor of the larynx: a case report. Eur Arch Otolaryngol. 2003;260:341–3.

    Article  Google Scholar 

  14. Allen AC, Spitz S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6:1–45.

    Article  CAS  PubMed  Google Scholar 

  15. Moore ES, Martin H. Melanoma of the upper respiratory tract and oral cavity. Cancer. 1955;8:1167–76.

    Article  CAS  PubMed  Google Scholar 

  16. Amin HM, Petruzzelli GJ, Husain AN, et al. Primary malignant melanoma of the larynx. Arch Pathol Lab Med. 2001;125:271–3.

    CAS  PubMed  Google Scholar 

  17. Morris LG, Wen YH, Nonaka D, et al. Melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck. Head Neck. 2008;30:771–5.

    Article  PubMed  Google Scholar 

  18. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112:362–73.

    Article  CAS  PubMed  Google Scholar 

  19. Yamaguchi Y, Fujio K, Shoda H, et al. IL-17B and IL-17C are associated with TNF-α production and contribute to the exacerbation of inflammatory arthritis. J Immunol. 2007;179:7128–36.

    CAS  PubMed  Google Scholar 

  20. von Euw E, Chodon T, Attar N, et al. CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J Transl Med. 2009;7:35.

    Article  Google Scholar 

  21. Cormary C, Gonzalez R, Faye JC, et al. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules. Cancer Gene Ther. 2004;11:497–507.

    Article  CAS  PubMed  Google Scholar 

  22. Garley M, Jablonska E, Grabowska SZ, et al. IL-17 family cytokines in neutrophils of patients with oral epithelial squamous cell carcinoma. Neoplasma. 2009;56:96–100.

    Article  CAS  PubMed  Google Scholar 

  23. Langowski JL, Zhang X, Wu L, et al. IL-23 promotes tumour incidence and growth. Nature. 2006;442:461–5.

    Article  CAS  PubMed  Google Scholar 

  24. Overwijk WW, de Visser KE, Tirion FH, et al. Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol. 2006;176:5213–22.

    CAS  PubMed  Google Scholar 

  25. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175:6177–89.

    CAS  PubMed  Google Scholar 

  26. Kryczek I, Wei S, Zou L, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178:6730–3.

    CAS  PubMed  Google Scholar 

  27. Wang L, Yi T, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206:1457–64.

    Article  CAS  PubMed  Google Scholar 

  28. Cormary C, Hiver E, Mariamé B, et al. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity. Cancer Gene Ther. 2005;2:963–72.

    Article  Google Scholar 

  29. Couderc B, Zitvogel L, Douin-Echinard V, et al. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther. 1998;5:163–75.

    CAS  PubMed  Google Scholar 

  30. Snow GB, VanDerEsch EP, Van Sloanten EA. Mucosal melanomas of the head and neck. Head Neck Surg. 1978;1:24–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beverly Y. Wang.

Additional information

Funded by grant number: NIH/NCRR 1UL1RR029893-01.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirikanjanapong, S., Lanson, B., Amin, M. et al. Collision Tumor of Primary Laryngeal Mucosal Melanoma and Invasive Squamous Cell Carcinoma with IL-17A and CD70 Gene Over-Expression. Head and Neck Pathol 4, 295–299 (2010). https://doi.org/10.1007/s12105-010-0200-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-010-0200-8

Keywords

Navigation